p120-catenin, α-catenin and E-cadherin are all thought to act as haploinsufficient tumor suppressors, whereby complete biallelic loss is only allowed under permissive conditions, like prior loss of p53 function (Shibata et al., 2007; Short et al., 2017). The gene discussed is CDH1; the disease is neoplasm.